Patent Assignment
Reel/Frame 057229/0388
Corrective Assignment to Correct the Assignee City of Residence Previously Recorded at Reel: 47050 Frame: 007. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2021-08-11
Pages: 4
Assignor
CEPHALON AUSTRALIA PTY. LTD.
Executed: 2013-08-13
Assignee
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
LEVEL 2, EPPING ROAD, MACQUARIE PARK, NSW, 2113, AUSTRALIA
Covered Property
(1)
Anti-CD38 Antibodies and Fusions to Attenuated Interferon Alpha-2B
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 11, 2016
From: CLARK, ADAM; POLLARD, MATTHEW; DOYLE, ANTHONY GERARD; BEHRENS, COLLETTE
To: TEVA PHARMACEUTICALS AUSTRALIA PTY. LTD.
Reel/Frame 039122/0970 →
Change of Name
Oct 3, 2018
From: CEPHALON AUSTRALIA PTY. LTD.
To: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
Reel/Frame 047050/0007 →
Corrective Assignment to Correct the the Spelling of the First Inventor Last Name and the Receiving Party Address. Previously Recorded at Reel: 039122 Frame: 0970. Assignor(S) Hereby Confirms the Assignment.
Jul 15, 2021
From: CLARKE, ADAM; POLLARD, MATTHEW; DOYLE, ANTHONY GERARD; BEHRENS, COLLETTE
To: CEPHALON AUSTRALIA PTY. LTD. (NOW TEVA PHARMACEUTICALS AUSTRALIA PTY. LTD.)
Reel/Frame 056890/0304 →